Search

Your search keyword '"P Christian Schulze"' showing total 212 results

Search Constraints

Start Over You searched for: Author "P Christian Schulze" Remove constraint Author: "P Christian Schulze" Topic business.industry Remove constraint Topic: business.industry
212 results on '"P Christian Schulze"'

Search Results

1. Virtual and Augmented Reality in Cardiovascular Care

2. Initial Invasive or Conservative Strategy for Stable Coronary Disease

3. Relation of left atrial function with exercise capacity and muscle endurance in patients with heart failure

4. Patent foramen ovale—When to close and how?

5. Feasibility of the Big 5—Jena eCS Protocol

7. Access Site Complications of Peripheral Endovascular Procedures: A Large, Prospective Registry on Predictors and Consequences

8. Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart

9. Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial

10. Cardiomyocyte Krüppel-Like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy

11. Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation

12. Risk of postoperative neurological exacerbation in patients with infective endocarditis and intracranial haemorrhage

13. Voltage-guided ablation in persistent atrial fibrillation—favorable 1-year outcome and predictors

14. Metabolomic profiling of patients with high gradient aortic stenosis undergoing transcatheter aortic valve replacement

15. Characterization of dendritic cells in human and experimental myocarditis

16. Begründung für die neuen LDL-Cholesterin-Zielwerte

17. Depression and anxiety in elderly patients with severe symptomatic aortic stenosis persistently improves after transcatheter aortic valve replacement (TAVR)

18. Improving exercise capacity and quality of life using non‐invasive heart failure treatments: evidence from clinical trials

19. Empfehlungen zum Notfallmanagement von Patienten mit permanenten Herzunterstützungssystemen

20. A Review on the Evolving Roles of MiRNA-Based Technologies in Diagnosing and Treating Heart Failure

21. Phytosterols and Cardiovascular Disease

22. Cardiovascular prognosis: a new role for ceramides and other cardiometabolites

23. Cellular inflammation in pulmonary hypertension: Detailed analysis of lung and right ventricular tissue, circulating immune cells and effects of a dual endothelin receptor antagonist

24. Effect of Vitamin D3 and Calcium Carbonate Supplementation on Muscle Strength in Postmenopausal Women Living with HIV

25. Prediction of short‐ and long‐term mortality in takotsubo syndrome: the InterTAK Prognostic Score

26. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking

27. Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee

28. Long-term safety and efficacy of combined percutaneous LAA and PFO/ASD closure: a single-center experience (LAAC combined PFO/ASD closure)

29. Aortic annulus measurement with computed tomography angiography reduces aortic regurgitation after transfemoral aortic valve replacement compared to 3-D echocardiography: a single-centre experience

30. Lipid lowering in patients 75 years and older

31. Concept and Design of a Novel Pulsatile Left Heart Assist Device-The PERKAT Left Ventricle System

32. Prognostic impact of acute pulmonary triggers in patients with Takotsubo syndrome : new insights from the International Takotsubo Registry

33. Impact of atrial fibrillation on outcome in takotsubo syndrome: Data from the international Takotsubo registry

34. Skeletal Muscle Function, Structure, and Metabolism in Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction

35. The impact of tricuspid annular geometry on outcome after percutaneous edge-to-edge repair for severe tricuspid regurgitation

36. Serum Biomarkers of Cardiovascular Remodelling Reflect Extra-Valvular Cardiac Damage in Patients with Severe Aortic Stenosis

37. Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease

38. Prognostic relevance of serum lactate kinetics in critically ill patients

39. Novel cardiovascular biomarkers in patients with cardiovascular diseases undergoing intensive physical exercise

40. Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls

41. Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease

42. Efficacy of temperature-guided cryoballoon ablation without using real-time recordings – 12-Month follow-up

43. Concept, Evaluation, and Future Perspectives of PERKAT® RV—A Novel Right Ventricular Assist Device

44. Resistance Training Reduces Skeletal Muscle Work Efficiency in Weight‐Reduced and Non–Weight‐Reduced Subjects

45. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial

46. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life

47. Therapeutic options in advanced heart failure

48. Rapid increases in nitrogen oxides are associated with acute myocardial infarction: A case-crossover study

49. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial

50. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure

Catalog

Books, media, physical & digital resources